| Name | Title | Contact Details |
|---|---|---|
Elizabeth Jaworski |
VP, Global General Counsel Chief of Staff and Head of Legal Operations | Profile |
Jackie Marks |
VP | Head, Enterprise Inspection Readiness & Operational Compliance | Profile |
Susan Hensley |
Senior Director, Regulatory Operations Regulatory Affairs Vaccines | Profile |
Tatiana Ishida |
Vice President, Head of Regulatory Affairs Marketed Products and Global Labeling | Profile |
Patrick Eagleman |
VP, Intellectual Property | Profile |
Medelis is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson`s, Alzheimer`s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. Our vision is to deliver high quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.
Accord Healthcare is a global provider of generic and specialty pharmaceuticals. Our focus on a rapidly expanding portfolio of affordable generic…
Alvogen is a multinational, privately owned pharmaceuticals company focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products. With more than 200 pharmaceutical projects in development and registration, the group`s product portfolio consists of a broad range of leading molecules for the treatment of conditions in the fields of: oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen has commercial operations in over 30 countries with 2,000 employees. North America is Alvogen`s single largest market and other key markets include: South-Korea, Romania, Bulgaria, Hungary, Taiwan, Russia and China.